Kochav Defense Acquisition
KCHV · NASDAQ
About KCHV
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- May 28, 2025
- Sector
- N/A
- Industry
- N/A
KCHV key statistics
- Market cap
- 360.05M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 47.60K
- Volume
- 36
- Open price
- $10.51
- High today
- $10.51
- Low today
- $10.51
- 52 Week high
- $10.52
- 52 Week low
- $10.07
Kochav Defense Acquisition (KCHV) at a glance
As of Oct 23, 2026, Kochav Defense Acquisition (KCHV) shares are priced at $10.51, giving the company a market cap of 360.05M and a price-to-earnings ratio of 0.00.
Volume so far is 36 shares, below the average of 47.60K shares a day.
Over the past year Kochav Defense Acquisition has ranged from $10.07 to $10.52, and now sits 98% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.